Anita Mangia

Bari, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.

Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients.

Journal: Frontiers in oncology
Published: May 05, 2021

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy.

The role of rapid on site evaluation on touch imprint cytology and brushing during conventional bronchoscopy.

Journal: Diagnostic cytopathology
Published: February 08, 2021

NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.

NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer.

Journal: Frontiers in oncology
Published: April 23, 2020

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.

Journal: Frontiers in oncology
Published: October 18, 2019

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

Journal: Cancers
Published: August 07, 2019

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.

Journal: Therapeutic advances in medical oncology
Published: July 11, 2019

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.

Tumor Infiltrating Lymphocytes and NHERF1 Impact on Prognosis of Breast Cancer Patients.

Journal: Translational oncology
Published: June 24, 2019

Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients.

Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients.

Journal: Cancers
Published: June 11, 2019

The Italian Rare Pancreatic Exocrine Cancer Initiative.

The Italian Rare Pancreatic Exocrine Cancer Initiative.

Journal: Tumori
Published: April 11, 2019

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients.

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients.

Journal: Translational oncology
Published: October 26, 2018

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Journal: Translational oncology
Published: September 26, 2018

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: March 12, 2018
Showing 1-12 of 49

Last Updated: 09/26/2026